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Abstract 
Wu-zi-yan-zong-wan (WZ), a combination of Fructus Lycii, Semen Cuscuta, 
Fructus Rubi, Semen Plantaginis, Fructus Schisandme, is generally indicated for 
promoting kidney functions and treating infertility. Evidence exists that some of the 
herbals ingredients in this traditional Chinese medicinal formula, such as Fructus 
Lycii [Gou-qi-zi], Fructus Rubi [Fu-pen-zi], and Fructus Schisandrae [Wu-wei-zi], 
possess antioxidant properties. However, relevant investigations on this formula and 
its modifications are rarely been reported. It is therefore hypothesized that WZ can 
produce protective effect on oxidative stress in the liver and the antioxidant 
properties of WZ may be eliminating improved by some of the component herbs. 
An aqueous extract of WZ showed free radical scavenging activity in the 
(Trolox Equivalence Antioxidant Capacity) TEAC assay system. Fructus Rubi was 
determined to be the most significant antioxidant herb among the ingredient herbs. 
An in vitro study using HepG2 cells was then used to test the effect of WZ and its 
modified or simplified formulae on oxidative stress induced by hydrogen peroxide or 
menadione. It was found that the WZ extract and some of its simplified formulae 
displayed antioxidant effect in cultured HepG2 cells. WZ and its simplified formulae 
were further tested using an in vivo mouse model against menadione-induced 
ii 
hepatotoxicity. The result indicated that WZ treatment could protect against 
menadione-induced hepatotoxicity in mice, as indicated by a significant decrease in 
serum alanine aminotransferase (ALT) activity. However, the biochemical index of 
liver injury was not paralleled by observation from histopathological assessment, 
which did not show any protective effect. 
In summary, the aqueous extract of WZ and some of its simplified formulae 
were shown to possess antioxidant properties in both in vitro and in vivo assay 
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Clinical and biomedical scientists are interested in antioxidants because 
they could retard the oxidative tissue damage by scavenging free radicals or lowering 
oxidative stress. There is also an increasing interest in the antioxidant effects of 
naturally occurring substances because of their potentials of being developed into 
nutritional supplements, health foods, and preventive medicines. 
1.1 Oxidation stress 
Oxidative stress has long been implicated in a number of neurodegenerative 
diseases, including Alzheimer's disease, Parkinson's disease, Huntington's disease 
and ischemic injury (Behl, 1994; Coyle, 1993; Markesbery, 1997; Simonian, 1996; 
Toufektsian, 2001). Overwhelming evidence also indicates that oxidative stress can 
lead to cell and tissue injury when the antioxidant status was altered by exposure to 
excessive oxidants. However, the same free radicals that are generated during 
oxidative stress are produced during normal metabolism (Montagnier, 1998). Thus, 
no one is able to avoid free radicals. 
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1.1.1 Free radicals 
Free radicals are highly reactive compounds that are created in the body 
during normal metabolic processes or introduced from the environment. Free radicals 
are inherently unstable, since they contain "extra" energy, the unpaired electrons. 
Free radicals are molecules with an odd number of electrons. They are potentially 
reactive in order to gain or lose one electron (Muriel, 1997). These reactive free 
radicals can cause damages to cells and tissues in certain pathways. DNA damage 
leads to cell injury, destruction of nucleotide coenzymes, disturbance to 
SH-dependent enzymes, covalent binding, membrane damage and lipid peroxidation 
(Slater, 1985). 
However, free radicals are involved in many activities in the body during 
oxidative metabolism and energy production. For example, free radicals are involved 
in: 
• Enzyme-catalyzed reactions 
• Electron transport in mitochondria 
• Signal transduction and gene expression 
• Activation of nuclear transcription factors 
• Anti-microbicidal action of neutrophils and macrophages 
• Aging and diseases 
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(Takahashi, 1998) 
Oxidants or reactive oxygen species (ROS) is a collective term that includes 
oxygen-derived radicals, such as superoxide (O2 • ') and hydroxyl radicals ( • OH), 
and non-radical derivatives of oxygen such as hydrogen peroxide (H2O2) and 
hypochlorous acid (HOCl). 
1.1.1.1 Hydrogen peroxide 
Hydrogen peroxide (H2O2) is thought to be an important precursor of highly 
reactive free radicals, and it has been reported to induce apoptosis in brain, liver, 
kidney and also other organs of the body (Ishikawa, 1999; Ratan, 1994; Bode, 
1997; Duru 2000). Apoptosis, also known as programmed cell death, is a form of 
cell death that occurs during several pathological situations in mutlicellular 
organisms and constitutes a common mechanism of cell replacement, tissue 
remodeling, and removal of damaged cells. Though, apoptosis is a complex 
process characterized by cell shrinkage, chromatin condensation, intemucleosonal 
DNA fragmentation, and formation of "apoptosis body". Hydrogen peroxide can 
readily cross the cell membranes and encounters transition metal ions, especially 
Fe2+ and Cu+，to form the aggressive • OH radical as in the Fenton reaction. On 
the other hand, transition metal ions can act as catalysts to stimulate the 
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formulation of the • OH from O2 • ‘ and H2O2，as in the Haber-Weiss reaction. 
Fenton reaction: 
H2O2 + Fe2+ + H+ HO • + Fe3+ + H2O 
Haber-Weiss reaction: 
0 2 . - + F e 3 + + 02 + Fe2+ 
2 O2 • - + 2H+ O2 + H2O2 
(Poli, 1994) 
1.1.1.2 Menadione 
Menadione (2-methyl-l, 4-naphthoquinone), also known as vitamin K3, is a 
potent oxidative stress inducer. It has been used as an effective and remarkably safe 
cytotoxic drug for treatment of several human tumors (Margolin, 1995; Tetef, 1995). 
Menadione induces apoptotic cell death through a poorly understood mechanism. It 
promoted oxidation of protein sulfhydryl groups in cytoskeletal protein, DNA 
fragmentation and alteration of calcium homeostasis. (Czaja，2003) The cytotoxic 
effect is thought to be related to ROS generated from the NADPH-mediated and 
cytochrome P-450 reductase-catalyzed redox cycling of menadione (Thor, 1982). 
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1.1.2 Diseases related to oxidative stress 
Oxidative stress is an underlying factor in health and disease. There are 
many diseases related to oxidative stress. More and more evidence is accumulating 
that a proper balance between oxidants and antioxidants is involved in maintaining 
health and longevity, and that altering this balance in favor of oxidants may result in 
pathological responses causing functional disorders and disease. Oxidative stress, 
rather than being the primary cause of disease, is more often a secondary 
complication in many disorders. Oxidative stress-related diseases include 
inflammatory bowel disease, retinal ischemia, cardiovascular disease and restenosis, 
AIDS, ARDS, and neurodegenerative diseases such as stroke, Parkinson's disease, 
and Alzheimer's disease (Montagnier, 1998). Such ailments may prove amenable to 
antioxidant treatment because there is a clear involvement of oxidative injury in 
these disorders. 
1.1.3 Liver Injury 
The liver is the largest organ in human body. It performs a number of 
functions, such as detoxification of metabolic waste products, e.g. deamination of 
amino acids to produce urea; destruction of spent red cells and reclamation of their 
constituents (in conjunction with the spleen); synthesis and secretion of bile; 
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synthesis of the plasma proteins including the clotting factors; synthesis of plasma 
lipoproteins; glucogen synthesis, gluconeogenesis; storage of glucogen, some 
vitamins and lipid (Thomas, 1989). 
However, it is very easy to cause damages to the liver. There is an endless 
list of different kinds of liver injury related to oxidative stress. It includes acute 
hepatitis, chronic hepatitis, granulomatous disease of the liver, hepatic manifestations, 
alcoholic liver injury, fatty liver, hyperbilirubinemia and cholestasis, hepatic pigment 
abnormalities, fibrosis and cirrhosis, cancer etc. 
On the other hand, the liver is playing a key role in antioxidant defense. It 
contains nearly all physiological antioxidants in the highest amount in the body. This 
organ is the main site for detoxification of xenobiotics and the decomposition of 
surplus ROS or other free radicals (Olinescu, 1992; Sies, 1985; Yagi, 1983). It is to 
be expected that when chemical intoxication (involving ROS) occurs, the increased 
formation of peroxides and decrease of antioxidants will only occur when the 
antioxidants pool in the liver are exhausted. The chemical intoxication of liver 
always leads to increase formation of lipid peroxidation in the blood plasma. Liver 




1.1.4.1 Importance of antioxidant 
Antioxidants are a conspicuous first-line defense against free radicals and 
are able to counteract or, at least, slow down all major steps in the process of free 
radical induction of injury (Olinescu, 2002). Antioxidants work in several ways: they 
may reduce the energy of the free radical, stop the free radical from forming, or 
interrupt the oxidizing chain reaction to minimize the damage caused by free radicals 
(Williams, 1997). In the course of lipid peroxidation they can act as oxygen 
quenchers, radical scavengers (quenching initial radicals such as hydroxyl radicals as 
well as quenching intermediate radicals such as peroxy and alkoxy radicals), or metal 
ion chelators (Diaz, 1997). Therefore, antioxidants in foods and supplements are 
being widely promoted for their health benefits and prevention of diseases. 
1.1.4.2 Examples of antioxidant 
Many vitamins and minerals act as antioxidant in their own right, such as 
catechin, vitamin E, vitamin C, beta-carotene, lutein, lycopene, vitamin B2, 
coenzyme QIO, cysteine, flavonoids, and polyphenols. They can provide powerful 
antioxidant protection for the body (Ames, 1993). 
Therefore consuming a wide variety of vitamins, minerals, and herbs that 
- 7 -
have an antioxidant effect may be the best way to provide the body with the most 
complete protection against free radical damage. 
1.2 Traditional Chinese Medicinal (TCM) formula Wu-zi-yan-zong-wan 
(WZ) 
1.2.1 The WZ medicinal formula 
Wu-zi-yan-zong-wan (WZ) is a traditional Chinese medicinal formula 
prescribed for promoting kidney functions, and treating infertility. The composition 
of the WZ recipe include Fructus Liiycii {Lycium barbarum or L, chinensis) 
[Gou-qi-zi], Semen Cuscutae {Cuscuta chinensis) [Tu-si-zi], Fructus Rubi {Rubus 
chingii) [Fu-pen-zi], Semen Plantaginis {Plantago asiatica or P. depressa) 
[Che-qian-zi], and Fructus Schisandrae (Schisandra chinensis) [Wu-wei-zi]. 
The WZ medicinal formula has a long history of usage and its composition 
is described in the Chinese Pharmacopoeia as: 
Frutus Lycii 400g 
Semene Cuscutae (stir-fried) 400g 
Frucuts Rubi 200g 
Semen Plantaginis (stir-fried with salt) lOOg 
Frucuts Schisandrae (steamed) 50g 
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According to the Pharmacopoeia (2000), all five ingredients are grounded 
into powder, sieved and mixed. To prepare "water-honey pills", 35-50 g of honey is 
added for each 100 g of powder, with adequate amount of water. The pills are taken 
orally, 9 g/dose, twice daily for "large-honey pills". 
1.2.2 Pharmacological actions of WZ 
Traditionally, Wu-zi-yan-zong-wan (WZ) is generally indicated for male 
"kidney deficiency". It means that the weakness of the kidney causes the decline in 
sexual and reproductive functions (Zhang, 1988). According to the Pharmacopoeia, 
WZ has a replenishing effect toward the kidney and indicated for manifestation by 
sexual dysfunction such as impotence, sterility, premature ejaculation, seminal 
emission, and dribbling of urine after micturition (Pharmacopoeia, 2002). 
Modem pharmacological studies indicated that WZ has the capacity of 
stimulating spermatogenesis and modulating the hormone levels in the rat model 
(Wang, 1993). Also, WZ has been demonstrated to regulate the liver function. It was 
reported that WZ prescription protected rat against alcohol induced liver damage by 
reducing lipid peroxidation. A reduction in alcohol-induced fatty liver and necrosis 
was also observed after WZ administration (Li, 1994). A preliminary clinical study 
also showed that WZ could improve the hepatotoxic conditions, as indicated by 
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decreased serum ALT and AST, activities in 28 out of 30 alcohol-intoxicated patients 
after a 20-month treatment (Liang, personal communication). This formula also 
inhibited alcohol induced liver damage in the rat model (Liang, personal 
communication). 
1.2.3 Pharmacological actions of individual herbs 
1.2.3.1 Fructus Lycii 
Fructus Lycii (FL), known in Chinese as "Gou-qi-zi", is one of the main 
ingredients in the WZ formula. It is the dried fruits of Lycium harharum. L. 
(Solanaceae). It benefits the liver and the kidney (according to the Chinese medical 
theory) and it is good for replenishing vital essence and improving eyesight. 
Recent studies showed that FL could suppress lipid peroxidation in 
erythrocytes (Ren, 1995) and inhibit tumor growth in mice (Liu, 1996). The FL 
extract also has been shown to possess anti-fatigue (Luo, 1999, 2000; Zhan, 1989) 
and anti-hypoxic (Li, 1999a, 1999b) activities. FL contains polysaccharides that have 
the ability to scavenge hydroxyl radicals, decrease the generation of MDA, inhibit 
the decrease of mitochondria fluidity induced by hydroxyl radicals, and alleviate the 
swelling of mitochondria induced by hydroxyl radicals (Wang, 2001). The aqueous 
extract of the herb protected the animals from carbon tetrachloride-induced liver 
- 1 0 -
damage, inhibited the fatty changes in the serum and liver, slightly inhibited fat 
deposition in the hepatocytes following liver damage induced by carbon tetrachloride, 
and fostered the regeneration of hepatocytes (Lu, 1964). 
In the WZ prescription, FL serves as the "emperor" and contributes to the 
main therapeutic action of the formula. 
1.2.3.2 Semen Cuscutae 
Semen Cuscutae (SC) is the seeds of Cuscuta chinensis Lam or C. australis 
R.Br., known as "Tu-si-zi" in Chinese. SC is usually used in treating and 
strengthening both liver and kidney disorders (Dictionary of Chinese Medicine, 
1993-1998). 
The aqueous extract of SC has been shown to inhibit aldose reductase 
(Matsuda, 1995) and scavenge free radical (Kwon, 1997; Bao, 2002). Semen 
Cuscutae could protect the mice's liver from carbon tetrachloride-induced 
hepatotoxicity (享P，1992). The activity of Na+，K+-ATP was increased by intragastric 
administration of aqueous extract of Semen Cuscutae. 
In the WZ formula, SC serves as the "emperor" and it is responsible for the 
main therapeutic action. 
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1.2.3.3 Fructus Rubi 
Fructus Rubi (FR)，"Fu-pen-zi", is the fruit of Rubus chingii Hu (Rosaceae). 
It is traditionally used to benefit the kidney, and arrest seminal discharge and 
excessive urination. It is able to strengthen the kidney functions (Dictionary of 
Chinese Medicine, 1993-1998). 
It was reported that Fructus Rubi was useful in protecting against t-BHP 
induced oxidative damage and might be capable of attenuating cytotoxicity of other 
oxidants (Yau, 2002). FR was also shown to increase the level of LH-releasing 
hormone and testosterone, whereas the levels of luteinizing hormone, follicle 
stimulating hormone and estradiol were decreased (Chen, 1996) 
FR is included in the WZ formula as the "minister" which plays a role in 
enhancing thetherapeutic effects of FL and FC. 
1.2.3.4 Semen Plantaginis 
Semen Plantaginis (SP) is derived from the dried seed of Platago astiatica 
L. or P. depressa Willd. and is known as "Che-qian-zi". It removes heat, causes 
diuresis and eliminates dampness, relieves dysuria, clears the eye and promotes 
expectoration (Pharmacopoeia, 2000). It is also used for treating diarrhea in other 
countries (WHO, 1999). 
The extract of SP showed hepatoprotective activity against carbon 
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tetrachloride induced toxicity in mice (Yun，1977). Moreover, SP showed antioxidant 
activity in in vitro assay (Yamamoto，1982). 
SP serves as the "assistant and envoy" in the WZ formula that helps in 
assisting other ingredients to boost up the therapeutic effect. 
1.2.3.5 Fructus Schisandrae 
Fructus Schisandrae (FS), "Wu-wei-zi", is derived from the dried fruit of 
Schisandra chinensis Baill (Magnoliaceae). FS is often used as a tonic and sedative 
drug (Dictionary of Chinese Medicine, 1993-1998). It produces an effect to arrest 
discharges, replenish qi, promote fluid secretion, tonify the kidney and induce 
sedation (Pharmacopoeia, 2000). 
FS exhibits a wide variety of pharmacological action including the 
anti-hepatotoxic effect. It is a strong antioxidant against carbon tetrachloride induced 
liver damage in rats (Ko, 1995a, 1995b). Its chemical components, such as 
Schisandrol A, can inhibit liver MDA formation in rats subjected to 50% ethanol 
induced hepatotoxicity (Lu, 1991). Schisandrin B enhances the activities of 
glutathione reductase and glutathione transferase in mice treated with carbon 
tetrachloride (Ip, 1995). 
Since FS is the component of smallest amount in the WZ formula, it serves 
as the "minister" to enhance the therapeutic effects of the main ingredients, FL and 
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sc. 
1.3 The relationship between the liver and the kidney 
The interrelationship between liver disease and kidney dysfunction has 
been recognized. Basically, there are three major categories of disease states support 
such interrelationship: (i) disorders involving the liver and kidney directly; (ii) 
primary disorders of the kidney with secondary hepatic involvement, and (iii) 
primary disorders of the liver with secondary renal dysfunction (Epstein, 1994). 
Although the understanding of the ways in which the liver affects renal process is 
inevitably incomplete, there is evidence showing the pathophysiological relation 
between the kidney and liver. Many patients who have renal functional abnormalities 
have liver disease as well, such as the association of parlnchymal liver disease with 
secondary impairment of renal function, deranged renal sodium handling, impaired 
renal water excretion and, impaired renal concentrating ability, hepatorenal syndrome, 
acute renal failure, glomerulopathies with cirrhosis or hepatitis, and impaired renal 
acidification (Epstein, 1978). These illustrate that kidney and liver are really closely 
related to each other physiologically and pathologically. 
In Traditional Chinese Medicine (TCM) theory, the liver stores blood and 
the kidney stores the essence of life. The blood of the liver depends on nourishment 
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from the essence in kidney, while the essence stored in the kidney depends on 
replenishment from the blood of liver. In TCM, it is believed that blood can develop 
into the essence of life, and vice versa. Therefore, it is widely said that the liver and 
the kidneys have a common source (Zhang, 1998). Pathologically, a deficiency of the 
essence in the kidney may lead to a deficiency of the blood in the liver. A long-term 
deficiency of the blood of the liver may cause a deficiency of the essence of life in 
the kidney. Therefore, in treating the deficiency of the yin of the liver or kidneys, a 
method is often used to reinforce the 少of both the liver and kidney. 
1.4 Objectives of the study 
Many herbal medicines for boosting kidney's function have been shown to 
delay the aging process, presumable through safe guarding kidney function and 
antioxidation. It is also proposed that the kidney function boosting medications might 
have an effect on regulating the function of other organs. As the theory of TCM goes, 
it is rational to hypothesize that kidney-targeting herbal medicines may produce a 
protective effect on the liver. 
Wu-zi-yan-zong-wan (WZ) is a well-known traditional Chinese medicinal 
formula for its therapeutic effect on infertility. In TCM, infertility is related to the 
dysfunction of kidney. Moreover, previous studies also showed that WZ protected 
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against on liver toxicity (Li, 1992; Li, 1994). Among the ingredients in the formula, 
Fructus Lycii (FL), Semen Cuscutae (SC) and Fructus Schisandrae (FS) have been 
reported to have strong antioxidant protective effect on liver toxicity (Yun, 1980; 
Kim, 1994; Kim, 1997; Liu, 1991; Li, 1991; Sinclair, 1998; Hankcke, 1999). 
Therefore, it is proposed that WZ might have an antioxidant effect with great 
potentials of developing into a therapeutic or food supplement. 
Moreover, it is proposed that simplifying the WZ traditional formula by 
eliminating one or more ingredients may be able to maintain or even improve the 
biological activity against oxidation. As a result of simplification, it will be more 
convenient and simplier to investigate the therapeutic effect as well as its mechanism 
by reducing any unnecessary interactions among the herbal ingredients. 
In the present study, the primary objective is to investigate the 
hepatoprotective effect of the aqueous extract of the WZ formula. The abilities of 
WZ formula to scavenge free radicals in vitro and protect mouse liver and 
hepatocytes from oxidants-induced damage were examined. In addition, the 
simplified WZ formulae were examined for their in vitro and in vivo antioxidant 
effects. 
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Chapter 2 
Preparation of Aqueous Extract of Wu-zi-yan-zong-wan 
2.1 Introduction 
Traditionally, most of the Chinese herbal medications are prepared by 
making decoction or formulating into pills. From ancient records and the official 
Chinese Pharmacopoeia, Wu-zi-yan-zong-wan is prepared in the form of "honey 
pills", in which the powdered herbs are mixed with honey and water. However, this 
kind of traditional dosage forni is inconvenient to prepare and be examined in 
experiments. Alternatively, aqueous extraction is used in the present study to prepare 
the WZ formula from crude herbs. 
In addition to the aqueous extracts in the form of freeze-dried powder 
prepared from crude materials, the ready-to-use herbal powders prepared from 
aqueous extract and supplied by Sheng Cheung Pharmaceutical Ltd. (a local herbal 
store) were also used for testing. 
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2.2 Materials and Methods 
2.2.1 Preparation of Wu-zi-yan-zong-wan (WZ) 
2.2.1.1 WZ extracts from raw materials (WZ-e) 
The constituents of Wu-zi-yan-zong-wan are mentioned in section 1.2.1. 
All ingredients were obtained from a local vendor (as shown in Figure 2.1) and 
authenticated by Mr. H. Xie. After grounding with a grinder, each of the herbal 
ingredients was soaked in distilled water (10 ml water per gram of powder), ultra 
sonicated for 30 minutes, and boiled at 100 "C under reflux for 3 hours. Afterward, 
the samples were cooled down to room temperature and filtered successively through 
cheesecloth and filter paper. Finally, the aqueous extract of Wu-zi-yan-zong-wan was 
dried by freeze-drying to afford a powder. 
For the simplified formulae, raw herbs were combined according to the 
scheduled shown in Table 2.1. The extraction process was the same as previously 
described. 
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Table 2.1. Composition of Wu-zi-yan-zong-wan (WZ) and its simplified 
formulae 
% in formula 34.78% 34.78% 17.39% 8.70% 4.35% 
WZ • • • • • 
(4)-l Z ^ Z Z 
(4)-2 ^ Z • • 
(4)-3 • • Z Z 
(4)-4 y Y Y ^ 
I(4)-5 ^ Y Y Y 
(3)-l y Y y 
(3)-2 • • • 
(3)-3 ^ ^ ^ OH ^ ^ z ( )-5 Z Z Z 3) 6  Z Z ( -7 ‘ ^ 83)9  ( -10 Z Z  ：2 1 ^2)-2 Z Z 3  ^)-4 ^ Z 5 Z 0-7 Z丨)-8  • :) 9 ^  )-10 ^ ‘� ’ �I - 1 9 -
2.2.1.2 WZ extracts from commercially available ready-to-use powders 
(WZ-p) 
Rather than performing the aqueous extraction using raw herbs, five 
different ingredients in powder form, which were manufactured by Sheng Cheung 
Pharmaceutical Ltd. in Taiwan were obtained from a local store, (as shown in the 
Figure 2.2). According to the manufacturer, the powders were made by freeze-drying 
of the aqueous extracts of herbs. These powders were shown to be free of heavy 
metals and pathogenic bacteria by our in-house testings. As per the manufacturer's 
instruction, the powders were prepared from raw herbs at a yield of 20% (w/w). 
In the experiments, powders of the ingredient herbs were mixed according 
to the schedule as shown in Table 2.1. 
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mmm 
mm 
Figure 2.1. Raw materials of ingredients in WZ formula. (WZ-e) 
Upper: Fructus Rubi, Fructus Lycii, Fructus Schisandrae 
Lower: Semen Plantaginis, Semen Cuscuta 
Figure 2.2 Aqueous extracts of ingredients in WZ formula from commercial 
source. (WZ-p) 
Upper: Fructus Rubi, Fructus Lycii, Fructus Schisandrae 
Lower: Semen Plantaginis, Semen Cuscuta 
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2.3 Results 
2.3.1 Extraction Yield for WZ-e 
The extraction efficiencies for WZ formula as well as its simplified 
formulae are shown in Table 2.2. The percentage yields of the extracts were 
estimated from the following equation: 
Percentage yield (%)= 
[Final weight after freeze-drying / raw material] x 100% 
There was a wide range in extraction yield (1.2-50.2%) among various herbal 
combinations materials into dried powder. The formula of (3)-8 gave the highest 
amount of dried aqueous extract with an extraction yield of 50.2%, while the formula 
(2)-5 gave the least amount of dried extract (1.2%). 
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Table 2.2. The table of percentage yield of WZ-e and its simplified formulae 
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Chapter 3 
In vitro Total Antioxidant Capacity of Aqueous Extracts of 
Wu-zi-yan-zong-wan and its Components 
3.1 Introduction 
3.1.1 Trolox Equavalent Antioxidant Capacity (TEAC) 
6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (Trolox) is a 
water soluble vitamin E analogue (Mantle, 2000). Trolox equivalent antioxidant 
capacity (TEAC) assay was developed to assess the total antioxidant capacity of the 
testing samples. This is a commonly used method to evaluate in vitro antioxidant 
effects. The assay, served as a measure of antioxidant capacity, is based on the 
efficacy of the tested material to scavenge 
2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) (ABTS) derived radicals (Arts, 
2001). The reaction involves the oxidation of ABTS to an intensely-colored 
nitrogen-centered radical cation, ABTS • +, which has an absorption maxima at 734 
nm (Figure 3.1). 
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I y = H - N = \ I 
I I Et Et 
ABTS radical cation 
at 734nm 
Figure 3.1 Oxidation of ABTS to ABTS • + radical 
3.1.2 Objectives 
In the present study, the TEAC assay was employed to measure the total 
antioxidant capacity of the aqueous extract of WZ formula as well as its simplified 
formulae. 
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3.2 Materials and methods 
3.2.1 Materials 
3.2.1.1 Reagents 
The chemicals employed in these studies were of reagent grade or 
equivalent quality. Potassium persulfate, ABTS, and Trolox were obtained from 
Sigma Chemical Co.. Milli-pore distilled water system was used. 
3.2.1.2 Instruments 
A spectroscopy system HP 8453E from Hewlett Packard was used to 
determine the absorbance of the samples. 
3.2.2 Methods 
3.2.2.1 Total Antioxidants: Trolox Equivalent Antioxidant Capacity (TEAC) 
A volume of 100 ml potassium persulfate (4.9 mM) was mixed with 100 
ml ABTS solution in distilled water (14 mM). It is then stood still for 24 hours to 
produce ABTS • ions. After 24 hours, the solution was diluted around 100-fold to 
maintain an OD reading of about 0.7 at 734 nm (Schlerier, 2002). However, the stock 
solution of Trolox was prepared in ethanol to enhance its solubility. 
The ABTS Reagent (1ml) was added to 0.1 ml sample or Torlox in a 25 mm 
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test tube. After standing at room temperature for one minute, optical density (OD) 
was taken using the UV-Vis Spectrophotometer. 
The percentage of antioxidant activity was calculated according to the 
formula: 
% of antioxidant activity = [ A(sample) —A (Trolox) / A(sample) ] x 100% 
3.2.3 Statistical analysis 
All analyses were performed for more than 3 times (n > 3). The percentage 
of antioxidant activity were estimated and expressed as mean 土 S.E. One-way 
analysis of variance (ANOVA) was performed using SPSS version 12.0.1 for 
Windows (SPSS Inc., US). Significant differences between means were determined 
where 户-values <0.05. 
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3.3 Results 
3.3.1 Antioxidant Capacity of Trolox 
The TEAC assay was calibrated with Trolox. As shown in Figure 3.2, 
Trolox caused a concentration-dependent decrease in absorbance. 
3.3.2 Antioxidant capacity of WZ-e formula 
Figure 3.3 shows the antioxidant capacity of the WZ-e formula. A 
concentration-dependent in absorbance was produced by the addition of WZ-e, with 
the inhibition concentration at 50% being 0.2-0.4 mg/ml. 
3.3.3 Antioxidant capacity of WZ-p formula 
Figure 3.4 shows the antioxidant capacity of WZ-p formula. WZ-p 
produced a concentration-dependent decrease in absorbance, with the inhibitory 
concentration at 50% being 4mg/ml. 
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Figure 3.2 Trolox standard curve. Data are expressed as mean 土 S.E., with n二3. 
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Figure 3.3 Antioxidant capacity of WZ-e formula. Data are expressed as mean 
土 S.E. with n=3. 
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Figure 3.4 Antioxidant capacity of WZ-p formula. Data are expressed as mean 
土 S.E. with n=3. 
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3.3.4 The total antioxidant capacity of WZ-e and its simplified formulae 
The in vitro antioxidant activity of WZ-e and its simplified formulae were 
quantified by TEAC assay (Table 3.1). The tests were performed at increasing 
concentrations of 0.2 mg/ml, 0.3 mg/ml, and 0.4 mg/ml. Data obtained at a test 
concentration of 0.2 mg/ml were listed in Table 3.1 for comparison. 
The results indicated that the simplified formulae (4)-l, (3)-2, (3)-3, (3)-9, 
(2)-5, (2)-8, (2)-9，SC and FR displayed stronger antioxidant capacity than the WZ-e 
extract. Meanwhile, FR is almost 40-fold more potent than WZ-e in the TEAC assay. 
However, it was also observed that formula (4)-3, (4)-4, (4)-5, (3)-l，（3)-4，(3)-5, 
(3)-6, (3)-7，(3)-8, (3)-10, (2)-l，(2)-3, (2)-4, (2)-6，�-7，（2)-10，FL and FS only 
exhibited weak antioxidant activity in the assay, while (2)-10 had the lowest TEAC 
value (1.16%). 
3.3.5 The total antioxidant capacity of WZ-p and its simplified formulae 
The TEAC assays on WZ-p and its simplified formulae were performed. 
However, no significant difference in the total antioxidant capacity was observed 
among the formulae (data not shown). Among, the simplified formulae, they had 
more or less the same free radical scavenging ability as assessed by the TEAC assay 
(data not shown). 
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Table 3.1 The total antioxidant capacity of WZ-e and its simplified 
formulae 
WZ-e 14.7 ±1.6 
(4)- l 59.5 ±7.8氺 
( 4 ) - 2 1 6 . 7 土 1.7 
(4)-3 1.8 ±0.0* 
(4)-4 6.5 ±0.1* 
( 4 ) - 5 3 . 3 土 0 . 1 * 
(3)-l 5.3 ±0.1* 
(3)-2 134.0 ±56.9* 
(3)-3 67.9 ±12.3* 
(3)-4 2.1 ±0.1* 
(3)-5 2.2 ±0.1* 
( 3 ) - 6 9 . 8 土 0 . 2 * 
(3)-7 10.2 ±0.1* 
( 3 ) - 8 1.4 土 0 . 1 * 
(3)-9 123.2 ±27.9* 
( 3 ) - 1 0 2 . 6 土 0 . 0 * 
(2)-l 3.3 ±0.0* 
(2)-2 11.9 ±0.2 
(2)-3 1.9 ±0.0* 
(2)-4 1.6 ±0.0* 
(2)-5 111.5 ±22.4* 
(2)-6 7.5 ±0.1* 
( 2 ) - 7 4 . 9 土 0 . 0 * 
( 2 ) - 8 7 2 . 8 土 1 0 . 3 * 
( 2 ) - 9 4 3 . 5 土 5 . 5 * 
(2)-10 1.2 ±0.0* 
FL 2.4 土 0.0* 
SC 60.8 土 5.6* 
FR 584.4 ±165.6* 
SP 11.7 ±0.2 
FS 1.5 ±0.0* 
Data were obtained at a test concentration of 0.2mg/mL 
* P < 0.05 based on comparison with WZ-e. 
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3.3.6 Synergistic effect of WZ-e and its simplified formulae 
In order to examine the synergistic effect of various combinations of 
component herbs, the antioxidant capacity of each component herb was adjusted 
according to its weight percentage in a formula. Synergistic effect can be observed if 
the antioxidant capacity of a formula is greater than the sum of its component herbs. 
The results indicated that WZ-e and most of its simplified formulae did not 
exhibit significant synergistic effect except for formula (2)-4 which was comprised 
o fFLand FS (Figure 3.5). 
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Figure 3.5 Possible synergistic effect of WZ-e and its simplified formulae, (a) 
WZ-e; (b)-(f) simplified formulae with 4 ingredients only; (g)-(p) 
simplified formulae with 3 ingredients only; (q)-(z) simplified 
formulae with 2 ingredients only. 
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3.3.7 Orthogonal analysis of WZ-e and its simplified formulae in TEAC 
assay 
Traditionally, fractional factorial designs have been used to determine 
the relative importance of each factor in the experiments. However, sometimes it is 
possible to obtain the same result through the Orthogonal analysis with fewer 
experimental groups. 
In the present study, a commercial software, SPSS, is used to run this 
Orthogonal analysis. By simply enter the factors in the experiment, SPSS lists all 
experimental groups. By analyzing the results of these experimental groups, the 
computer program will identify the critical element among all factors. In the present 
case, there are 5 ingredients (factors) in the WZ formula and 8 experiment groups 
were suggested by the computer program. They are (2)-8, (2)-3, WZ, (2)-l，(2)-7, 
(3)-10，FSand (2)-5. 
The results of Orthogonal analysis (Table 3.2) showed that only FR had a 
significant effect {P < 0.05) in the formulae. It suggested that FR was a critical 
component in the WZ formulae as far as the antioxidant capacity was concerned. 
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Table 3.2 Orthogonal analysis of antioxidant capacity data from WZ-e and 




SP 0.365 � 
FS 0.093 
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3.4 Discussion 
The Trolox equivalent antioxidant capacity (TEAC) assay was performed in 
order to determine in vitro antioxidant activity of the WZ formula. Both WZ-e and 
WZ-p were tested along with their simplified formulae. 
Both WZ-e and WZ-p exhibited concentration-dependent antioxidant effect 
in the TEAC assay. By comparing the concentration-response curves for WZ-e and 
WZ-p, it is clearly shown that WZ-e is 10-fold stronger than WZ-p. Although the 
manufacturer claimed that the WZ-p ingredients were prepared from raw herbs at a 
yield of 20%, results obtained from the TEAC assay indicated that the aqueous 
extract of WZ-e was much more potent than WZ-p. One possible reason is that the 
antioxidant compounds present in the powder had at least partially, degraded over 
time. 
Contradicting results were obtained when the antioxidant activity of WZ-e 
and its simplified formulae were compared. It is obvious that (3)-2, (3)-9, (2)-5, and 
FR displayed higher antioxidant activity than that of WZ-e. Interestingly, formulae 
(3)-2, (3)-9 and (2)-5 all contained both SC and FR. However, not all the 
combinations containing SC and FR are effective in scavenging free radicals. 
Therefore, it is premature to draw conclusion that SC and FR are the major 
component contributing to the antioxidant activity of WZ. 
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By comparing the antioxidant capacity of a formula and the arithmetic sum 
of those of its component herbs, synergistic effect was observed between FL and FS 
(formula (2)-4). However, both FL and FS had very weak antioxidant activity in the 
TEAC assay. 
The result obtained from Orthogonal analysis (Table 3.2) indicated that FR 
is the most important ingredient in the WZ prescription as far as the antioxidant 
capacity is concerned. Therefore, this is consistent with the finding that FR has the 
greatest antioxidant capacity in the TEAC assay. 
While the exact chemical composition of FR is still unclear, it is possible 
that phenolic compounds present in FR are responsible for the free radical 
scavenging activity. In this connection, aqueous extract of FR has been reported to 
protect against tert-butyl hydroperoxide-induced oxidative damage (Yau, 2002). 
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Chapter 4 
Antioxidant Activity of Aqueous Extracts of Simplified Formulae of 
Wu-zi-yan-zong-wan In Vitro 
4.1 Introduction 
4.1.1 In vitro antioxidant 
Based on the positive findings in the TEAC assay, further antioxidant 
assays were carried out using cellular system. 
The cell line, HepG2，used in this study was obtained from ATCC, with the 
cells being originated from a 15-year-old male Caucasian. These human hepatocytes 
are used to carry out an in vitro cellular testing on the performance against oxidative 
stress. By using human hepatocytes, it is more reliable and reasonable to make 
predictions of in vivo studies. 
4.1.2 Antioxidant effect of Catechins 
Tea catechins and polyphenols are effective scavengers of reactive oxygen 
species in vitro and may also function indirectly as antioxidants through their effects 
on transcription factors and enzyme activities. Catechins can act as chain-breaking 
antioxidants by scavenging chain-propagating peroxyl radicals due to the presence of 
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a phenolic hydroxyl group at the 3'-position, and a hydroxy! group at the 5'-position, 
which both have the ability to scavenge free radicals in vitro (Nanjo, 1996; 
Rice-Evans, 1996; Guo, 1999). It has also been reported that green tea catechins have 
a cytoprotective effect against chemical-induced cell injury in primary cultured 
hepatocytes (Miyahawa, 1997; Yokozawa, 2000). 
4.1.3 MTT assay 
Determinations of cellular proliferation, viability and activation are key 
areas in a wide variety of cell biological approaches. The MTT assay is based on the 
cleavage of the yellow tetrazolium salt MTT (3-[4,5-dimethylthiazo 12-yl]-2,5 
-diphenyl tetrazolium bromide) to purple formazan crystals by metabolically active 
cells (Figure 4.1) (Vistica’ 1991; Maehara Y，1986; Slater, 1963). An increase in the 
number of viable cells would result in an increase in the total metabolic activity in 
the sample, thus the amount of purple formazan crystals formed, which could be 
quantified by measuring in the absorbance at 595nm. 
Comparing with other labeling methods, MTT assay is safe, accurate, 
sensitive, fast and easy to operate. Therefore, it is widely used nowadays. 
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CH3 CH3 
MTT Formazan 
Figure 4.1 Metabolism of MTT to a formazan salt in viable cells. 
4.1.4 Objectives 
The present study was conducted to determine whether the aqueous extract 
of WZ-e and WZ-p have antioxidant activity in the cellular system. An oxidative 
stress inducing agent, such as hydrogen peroxide and menadione, was added to 
promote free radical production or even cause cell death. In addition, cell viability 
was determined in simplified formulae of WZ-e and WZ-p pretreated cells in order to 
investigate the effect between the original WZ formula and its components. It was 
hypothesized that the simplified formulae may have a even stronger antioxidant 
effect than the WZ formula. 
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4.2 Materials and methods 
4.2.1 Materials 
4.2.1.1 Cell Culture 
The hepatoblastoma HepG2 cell line was obtained from American Type 
Culture Collection (ATCC). RPMI 1640 medium, calf serum and trypsin were 
provided by GIBCO. Culture flasks (75mm^) from IWAKI Co. for cell culturing and 
96-well cell culture cluster from Costar Coming Incorporated were used. 
4.2.1.2 Reagents 
Menadione, Sodium chloride, (Tris) Trisma Base, EDTA, Potassium 
chloride, Sodium phosphate, potassium phosphate, SDS were obtained from Sigma; 
catechin from Aldrich Chemical Co. and hydrogen peroxide from BDH Labotatory 
Supplies. MTT assay kit was provided by Amersham Life Science. 
4.2.2 Methods 
4.2.2.1 Cell Culture 
HepG2 cells were cultured in RPMI 1640 medium (GIBCO) supplemented 
with 10% heat-inactivated calf serum at 37"C in 5% CO2 in a humidified cell 
incubator. The medium was changed every 2 days. For examining the effect of 
- 4 7 -
Wu-zi-yan-zong-wan on cell death induced by H2O2, cells were pre-treated with WZ 
at increasing concentrations ranging from 0 ug/ml to 10000 ug/ml for 24 hours. 
Immediately after the treatment with WZ, H2O2 was applied at a concentration of 0.5 
mM for 24 hours. The control group was left untreated. 
4.2.2.2 MTT Cytotoxicity Assay 
Cell viability was determined using an MTT assay kit according to the 
manufacturer's protocol. After drug treatment, 10 ul of MTT labeling reagent was 
added to each well, and the micro-titer plates were incubated for 4 hours. The cells 
were then incubated in 100 ul of the solubilization solution overnight. Absorbance 
was measured with a microtiter plate reader (Spectramax 250 microplate UV/Vis 
spectrophotometer) at 595 nm. 
4.2.3 Statistical analysis 
All analyses were performed for more than 3 times (n > 3). The data were 
expressed as mean 土 S.E. One-way analysis of variance was performed by ANOVA 
procedures using SPSS version 12.0.1 for Windows (SPSS Inc., US). Significant 
differences between means were determined when P-values <0.05. 
- 4 8 -
4.3 Results 
4.3.1 The effect ofWZ^e formula on HepG2 cells 
A dose-response experiment of WZ-e was performed in order to obtain an 
optimum concentration for further investigation. A biphasic dose-response was 
observed, with a steep rising slope from 1 mg/ml to 4 mg/ml followed by an abrupt 
decline (Figure 4.2). As the concentration increased from Omg/ml to 3mg/ml, the 
number of viable cells also increased. However, it is also observed that there was a 
decrease in number of viable cells as the concentration increased from 4mg/ml to 
1 Omg/ml. The sub optimal concentration of WZ-e applied on HepG2 cell was 
determined to be 3 mg/ml. 
4.3.2 The effect of hydrogen peroxide on HepG2 cells 
Figure 4.3 shows a dose response curve of hydrogen peroxide on HepG2 
cell. The lethal concentration at 50% (LC50) of hydrogen peroxide was found to be 
O.SmM. This concentration of hydrogen peroxide was used in all subsequent 
experiments. 
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Figure 4.2 The effect of aqueous WZ-e extract on HepG2 cells. Increasing 
concentrations of WZ extract were added to hepatocytes and cultured 
for 24 hours. The viability of hepatocytes was determined by MTT 
assay. Data are expressed as mean 土 S.E. (n = 8). 
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Figure 4.3 The effect of hydrogen peroxide (H2O2) on HepG2 cells. Increasing 
concentrations of hydrogen peroxide were added to hepatocytes and 
cultured for 24 hours. The viability of hepatocytes was determined 
with MTT assay. Data are expressed as mean 土 S.E. (n = 8). 
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4.3.3 The effect of menadione on HepG2 cells 
Increasing concentrations of menadione (dissolved in DMSO) were added 
to HepG2 hepatocytes. A dose response curve was shown in Figure 4.4. The LC 50 of 
meandione was determined to be 0.4 mg/ml. 
4.3.4 The effect of catechin on HepG2 cells 
As shown in Figure 4.5，catechin did not affect the viability of HepG2 cells 
up to a concentration of 0.01 mg/ml. Apparently, viable cell number was increased by 
higher concentrations of catechin, as indicated by higher absorbance in the MTT 
assay. Thus, 0.1 mg/ml of catechin was used as a positive control in subsequent 
assays. 
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Figrue 4.4 The effect of menadione on HepG2 cells. Menadione was added to 
hepatocytes and cultured for 24 hours. The viability of hepatocytes 
was determined by MTT assay. Data are expressed as mean 士 S.E. (n 
= 8 ) . 
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Figure 4.5 The effect of catechin on HepG2 cells. Catechin was added to 
hepatocytes and cultured for 24 hours. The viability of hepatocytes 
was determined by MTT assay. Data are expressed as mean 士 S.E. (n 
=8). 
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4.3.5 The effect of WZ-e and its simplified formulae on hydrogen peroxide 
-induced cytotoxicity in HepG2 cells 
As shown in Figures 4.6 - 4.9, formulae (4)-l，（3)-2, (3)-4，FL and SC 
produced significant protective effect on hydrogen peroxide-induced cytotoxicity, 
with the degree of protection being larger than that of WZ-e. However, none of the 
combinations could offer a complete protection against cytotoxicity induced by 
hydrogen peroxide. 
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Figure 4.6 The effect of WZ-e and simplified formulae on hydrogen 
peroxide-induced toxicity in HepG2 cells. The HepG2 cells were 
treated with WZ-e or its simplified formulae (at a concentration of 3 
mg/ml) for 24 hours at 37 V with 5% CO2. MTT assay was 
performed after treating with hydrogen peroxide at concentration 0.5 
mM for 24 hours. Data are expressed as mean 土 S.D. (n = 4) 
+ P < 0.05 compared with control group. 
* P < 0.05 compared with hydrogen peroxide-treated control group. 
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Figure 4.7 The effect of WZ-e and simplified formulae on hydrogen 
peroxide-induced toxicity in HepG2 cells. The HepG2 cells were 
treated with WZ-e or its simplified formulae (at a concentration of 3 
mg/ml) for 24 hours at 37 °C with 5% CO2. MTT assay was 
performed after treating with hydrogen peroxide at concentration 0.5 
mM for 24 hours. Data are expressed as mean 土 S.D. (n = 4) 
+ P < 0.05 compared with control group. 
* P < 0.05 compared with hydrogen peroxide-treated control group. 
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Figure 4.8 The effect of WZ-e and simplified formulae on hydrogen 
peroxide-induced toxicity in HepG2 cells. The HepG2 cells were 
treated with WZ-e or its simplified formulae (at a concentration of 3 
mg/ml) for 24 hours at 37 °C with 5% CO2. MTT assay was 
performed after treating with hydrogen peroxide at concentration 0.5 
mM for 24 hours. Data are expressed as mean 土 S.D. (n = 4) 
+ P < 0.05 compared with control group. 
* P < 0.05 compared with hydrogen peroxide-treated control group. 
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Figure 4.9 The effect of WZ-e and simplified formulae on hydrogen 
peroxide-induced toxicity in HepG2 cells. The HepG2 cells were 
treated with WZ-e or its simplified formulae (at a concentration of 3 
mg/ml) for 24 hours at 37 °C with 5% CO2. MTT assay was 
performed after treating with hydrogen peroxide at concentration 0.5 
mM for 24 hours. Data are expressed as mean 土 S.D. (n = 4) 
+ P < 0.05 compared with control group. 
* P < 0.05 compared with hydrogen peroxide-treated control group. 
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4.3.6 The effect of WZ-e and its simplified formulae on menadione-induced 
cytotoxicity in HepG2 cells 
As shown in Figures 4.10 - 4.13, formulae (2)-l，(2)-5, (2)-6, (2)-8，（2)-9 
and (2)-10 produced significant protective effect on menadione-induced cytotoxicity, 
with the degree of protection being larger than that of WZ-e. However, none of the 
combinations could offer a 100% protection. 
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Figure 4.10 The effect of WZ-e and simplified formulae on 
menadione-induced toxicity in HepG2 cells. The HepG2 cells 
were treated with WZ-e or its simplified formulae (at a 
concentration of 3 mg/ml) for 24 hours at 37°C with 5% CO2. MTT 
assay was performed after treating with menadione at concentration 
of 0.5 mM for 24 hours. Data are expressed as mean 土 S.D. (n = 4) 
+ P < 0.05 compared with control group. 
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Figure 4.11 The effect of WZ-e and simplified formulae on 
menadione-induced toxicity in HepG2 cell line. The HepG2 cells 
were treated with WZ-e or its simplified formulae (at a 
concentration of 3 mg/ml) for 24 hours at 37°C with 5% CO2. MTT 
assay was performed after treating with menadione at concentration 
of 0.5 mM for 24 hours. Data are expressed as mean 土 S.D. (n = 4) 
+ P < 0.05 compared with control group. 
* P < 0.05 compared with menadione-treated control group. 
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Figure 4.12 The effect of WZ-e and simplified formulae on menadione-induced 
toxicity in HepG2 cell line. The HepG2 cells were treated with 
WZ-e or its simplified formulae (at a concentration of 3 mg/ml) for 
24 hours at 37°C with 5% CO2. MTT assay was performed after 
treating with menadione at concentration of 0.5 mM for 24 hours. 
Data are expressed as mean 土 S.D. (n = 4) 
+ P < 0.05 compared with control group. 
* P < 0.05 compared with menadione-treated control group. 
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Figure 4.13 The effect of WZ-e and simplified formulae on 
menadione-induced toxicity in HepG2 cell line. The HepG2 cells 
were treated with WZ-e or its simplified formulae (at a 
concentration of 3 mg/ml) for 24 hours at 37°C with 5% CO2. MTT 
assay was performed after treating with menadione at concentration 
of 0.5 mM for 24 hours. Data are expressed as mean 土 S.D. (n = 4) + P < 0.05 compared with control group. * P < 0.05 compared with menadione-treated control group. 
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4.3.7 The effect of WZ-p on HepG2 cells 
Different concentrations of WZ-p (0—10 mg/ml) were added into each 
well containing HepG2 cells. It is observed that there was an increase in viable cells 
as the WZ-p concentration also increased from Omg/ml to 3mg/mL Alternatively, as 
the concentration of WZ-p increased from 3mg/ml to 1 Omg/ml, a decreased in 
number of viable cells was demonstrated. As shown in Figures 4.14，WZ-p produced 
a biphasic effect on the viability of HepG2 cells, with the enhancement of cell 
survival being optimal at 3mg/ml. 
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Figure 4.14 The effect of aqueous WZ-p extract on HepG2 cells. Different 
concentrations of WZ-p extract were added to hepatocytes and 
cultured for 24 hours. The viability of hepatocytes was determined 
with MTT assay. Data are expressed as mean 土 S.E. (n = 8). 
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4.3.8 The effect of WZ-p and its simplified formulae on hydrogen 
peroxide-induced cytotoxicity in HepG2 cells. 
As shown in Figures 4.14 - 4.17，formulae (4)-2, (3)-l, (3)-2, (2)-8，and 
(2)-9 produced significant protective effect on hydrogen peroxide induced 
cytotoxicity, with the degree of protection being larger than that of WZ-p However, 
none of the combinations could offer a 100% protection. 
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Figure 4.15 The effect of WZ-p and simplified formulae on hydrogen 
peroxide-induced toxicity in HepG2 cell line. The HepG2 cells were 
treated with WZ-p or its simplified formulae (at a concentration of 3 
mg/ml) for 24 hours under 37 °C with 5% CO2. MTT assay was 
performed after treating with hydrogen peroxide at concentration of 
0.5 mM for 24 hours. Data are expressed as mean 土 S.D. (n = 4) 
* P < 0.05 compared with hydrogen peroxide treatment group 
+ P < 0.05 compared with control group 
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Figure 4.16 The effect of WZ-p and simplified formulae on hydrogen 
peroxide-induced toxicity in HepG2 cell line. The HepG2 cells were 
treated with WZ-p or its simplified formulae (at a concentration of 3 
mg/ml) for 24 hours under 37 °C with 5% CO2. MTT assay was 
performed after treating with hydrogen peroxide at concentration of 
0.5 mM for 24 hours. Data are expressed as mean 土 S.D. (n = 4) 
* P < 0.05 compared with hydrogen peroxide treatment group 
+ P < 0.05 compared with control group 
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Figure 4.17 The effect of WZ-p and simplified formulae on hydrogen 
peroxide-induced toxicity in HepG2 cell line. The HepG2 cells were 
treated with WZ-p or its simplified formulae (at a concentration of 3 
mg/ml) for 24 hours under 37 °C with 5% CO2. MTT assay was 
performed after treating with hydrogen peroxide at concentration of 
0.5 mM for 24 hours. Data are expressed as mean 土 S.D. (n = 4) 
* P < 0.05 compared with hydrogen peroxide treatment group 
+ P < 0.05 compared with control group 
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Figure 4.18 The effect of WZ-p and simplified formulae on hydrogen 
peroxide-induced toxicity in HepG2 cell line. The HepG2 cells were 
treated with WZ-p or its simplified formulae (at a concentration of 3 
mg/ml) for 24 hours under 37"C with 5% CO2. MTT assay was 
performed after treating with hydrogen peroxide at concentration of 
0.5 mM for 24 hours. Data are expressed as mean 土 S.D. (n 二 4) 
* P < 0.05 com ared with hydrog n peroxide treatment group 
+ P < 0.05 compared with control group 
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4.3.9 The effect of WZ-p and its simplified formulae on menadione-induced 
cytotoxicity in HepG2 cells. 
As shown in Figures 4.19 - 4.22, formulae (4)-l，(4)-4, (4)-5, (3)-6, (3)-7 
and (3)-9 produced significant protective effect on menadione-induced cytotoxicity, 
with the degree of protection being larger than that of WZ-p. However, none of the 
combinations could offer a 100% protection. 
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Figure 4.19 The effect of WZ-p and simplified formulae on menadione-induced 
toxicity in HepG2 cell line. The HepG2 cells were treated with 
WZ-p or its simplified formulae (at a concentration of 3 mg/ml) for 
24 hours at 37°C with 5% CO2. MTT assay was performed after 
treating with menadione at concentration of 0.5 mM for 24 hours. 
Data are expressed as mean 土 S.D. (n = 4) 
* P< 0.05 compared with hydrogen peroxide treatment group 
+ P < 0.05 compared with control group 
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Figure 4.20 The effect of WZ-p and simplified formulae on menadione-induced 
toxicity in HepG2 cell line. The HepG2 cells were treated with 
WZ-p or its simplified formulae (at a concentration of 3 mg/ml) for 
24 hours at 37°C with 5% CO2. MTT assay was performed after 
treating with menadione at concentration of 0.5 mM for 24 hours. 
Data are expressed as mean 士 S.D. (n = 4) 
* P < 0.05 compared with menadione treatment group 
+ P < 0.05 compared with control group 
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讓i墨囊i議l.i i u 丄 iMMALIi� c / / / / / / / / / / / / / / & Figure 4.21 The effect of WZ-p and simplified formulae on menadione-induced toxicity in He G2 cell line. The HepG2 cells were treated withWZ-p or its simplified formulae (at a concentration of 3 mg/ml) for24 hours at 37°C with 5% CO2. MTT assay was p rform aftereating with endaione at concentr ti  of 0.5 mM for 24 hours.Data are expressed s mean 土 S.D. (n = 4) 
* P < 0.05 compared with menadione treatment group 
+ P < 0.05 compared with control group 
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Figure 4.22 The effect of WZ-p and simplified formulae on menadione-induced 
toxicity in HepG2 cell line. The HepG2 cells were treated with 
WZ-p or its simplified formulae (at a concentration of 3 mg/ml) for 
24 hours at 37"C with 5% CO2. MTT assay was performed after 
treating with menadione at concentration of 0.5 mM for 24 hours. 
Data are expressed as mean 土 S.D. (n = 4) 
* P < 0.05 compared with menadione treatment group 
+ P < 0.05 compared with control group 
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4.4 Discussion 
Reactive oxygen species and other free radicals are considered to be 
important causative factors in the development of age-related diseases such as 
neurodegenerative diseases, cancer, and cardiovascular diseases. Therefore intense 
research is being undertaken all over the world in the search for preventive or 
therapeutic agents. 
Hydrogen peroxide can induce apoptosis and the loss of mitochondrial 
membrane potential in HepG2 cells. Hydrogen peroxide could generate hydroxyl 
radical, an extremely potent oxidant. Menadione, on the other hand, generates 
reactive oxygen intermediates and causes cytotoxicity by redox cycling. Our results 
showed that the addition of menadione to HepG2 cells produced a 
concentration-dependent loss of cell viability. Both of H2O2 and menadione increase 
oxidative stress in HepG2 cells, leading to the decrease in cell viability or even cell 
death. The herbal samples, which were found to possess antioxidant activity, were 
studied to determine their ability to protect against oxidative stress. 
Alternatively, catechin was prepared in different concentrations to construct 
achieve a concentration curve in order to determine an optimal concentration as a 
standard. However, it clearly shows a proliferation effect on HepG2 cells. Catechin 
has been widely studied as a strong and effective antioxidant on both in vitro and in 
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vivo assay. It was reported that tea catechins inhibit cellular lipid peroxidation and 
reduce cytotoxicity in HepG2 cells (Murakami, 2002; Huang, 2003; Feng, 2001; Liu, 
2003). Thus, catechin was used as a positive control in the assays. 
Results obtained from the present study indicated that there was no sample 
capable of providing a complete protection. However, a number of hemal 
combinations displayed stronger protective effect than the complete WZ-e formula 
itself. Similarly, some of simplified formulae of WZ-p protected against cytotoxicity 
induced by hydrogen peroxide or menadione. However, a critical component herb for 
the cytoprotective effect could not be identified from both studies. 
It is believed that there are many unknown factors that may affect the 
results of WZ-e and WZ-p experiments. While WZ-e was extracted in our laboratory 
and the water extract was freeze-dried into powder, WZ-p was obtained from the 
market as a ready-to-use powder. Neither the quality of the raw herbs used, nor the 
processing procedure of these commercial products is known It is also uncertain 
about how long the products have been in the market. The antioxidant activity of the 
product may lose if it has been shelved at room temperature for a long period of time. 
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Chapter 5 
Effect of Aqueous Extract of Wu-zi-yan-zong-wan on Menadione 
-Induced Oxidative Damage in Mouse Liver 
5.1 Introduction 
Liver function tests, such as the measurement of plasma alanine 
aminotransferase (ALT) activity test, are used for the differential diagnosis of liver 
diseases or injuries and monitor for the treatment response. Although ALT is widely 
presented in a variety of tissues, it can be used as biochemical indicator for chronic 
liver disease and liver damage. The major source of plasma/ serum ALT is the liver; 
an increase in plasma ALT activity can be used for the assessment of the extent of 
liver damage. In this regard, elevated serum levels are, in particular, found most 
commonly in hepatitis, cirrhosis, and obstructive jaundice (Hemy, 1974; Toyoda， 
2004). Spectrophotometric measurement of ALT activity was based on the oxidation 
of NADH by lactate dehydrogenase (LDH). ALT catalyzes the transfer of the amino 
group from alanine to 2-oxoglutarate, to form glutamate and pyruvate. The pyruvate 
formed is then reduced to lactate in the presence of LDH, with simultaneous 
oxidation of the reduced nicotinamide adenine dinucleotide (NADH). The rate of 
decrease in absorbance at 340 run is directly proportional to ALT activity (Bergmeyer, 
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1977). 
ALT 
L-Alanine + 2-Oxoglutarate -> Pyruvate + L-Glutamate 
LDH 
Pyruvate + NADH+ H+ + D-Lactate + NAD+ + H2O 
s 
The aqueous extract of WZ-e formula showed an antioxidant capacity on 
TEAC assay in vitro. Therefore, it is hypothesized that WZ-e can also produce a 
hepato-protective effect on menadione-induced toxicity. A mouse model was 
established to study the in vivo effect of the herbal preparation. Animal models would 
provide data more relevant to the situation in human. In animal experiments, test 
samples are usually administered through gastrointestinal tract or other parentemal 
routes; the active ingredients will be absorbed into the blood stream before exerting 
their effects on distal targets. The antioxidant activities of WZ-e extract as well as its 
simplified formulae were therefore examined using the mouse model of menadione 
hepatotoxicity. 
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5.2 Materials and methods 
5.2.1 Materials 
5.2.1.1 Animals 
ICR mice (18-20 g) were supplied by the Laboratory Animal Services 
Center (LASEC), The Chinese University of Hong Kong. They were acclimated 
under the conditions of 22-25 °C and a 12-hour light-dark cycle before start of the 
experiments. They were supplied with standard rodent chow and allowed free access 
to tap water. 
5.2.1.2 Reagents 
Alanine aminotransferase (ALT) assay kit from Stanbio Laboartory was 
used. Menadione, heparin, and sodium chloride (NaCl) were obtained from Sigma 
Chemical Co. (St. Louis, MO, USA). All other chemicals used were of analytical 
grade. 
5.2.1.3 Apparatus 
UV spectrophotometer from HP, microscopic illuminator was obtained 
from Leica Microsystem Ltd., Reicheij-Jung microtome at 5um thick. 
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5.2.2 Methods 
5..2.2.1 Animal treatments 
ICR mice were divided into 6 groups on day 0 and housed separately in the 
LASEC. Different concentrations of WZ extract as well as the selected simplified 
formulae according to Orthogonal analysis [(2)-8，(2)-3, WZ, (2)-l, (2)-7，（3)-10，FS, 
and (2)-5] were prepared in distilled water. The extract was administered daily to 
mice by intragastric feeding at 0.42 g/kg/day, 1.25 g/kg/day, and 3.75 g/kg/day dose 
levels for 7 days. For the control group, mice were given 0.2 ml saline each day. As 
for the positive control group, mice were treated with 0.2ml catechin (1 mg/ml) daily 
(Yamaguchi, 1991; Hayek, 1997). All groups were allowed free access to standard 
rodent chow and tap water throughout the experiment. After 7 days of drug treatment, 
a single dosage (60 mg/kg in DMSO) of menadione was given intraperitonally to 
each mouse to induce hepatic oxidative damage. Animals were sacrificed 24 hours 
thereafter (Radjendirane, 1997). 
5.2.2.2 Collection of samples 
All mice were scarified 24 hours after menadione administration. Blood 
was collected for serum preparation while the liver was removed after perfusion with 
saline and 4% PFA. The liver samples were immersed in 4% PFA for fixation for 3 
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days. This was followed by dehydrating, processing, embedding, sliding and staining 
(Haematoxylin and Eosin) procedures. The histopathology of the liver was then 
investigated. 
5.2.2.3 Marker enzyme measurement (ALT) 
Plasma ALT activities was measured using Stanbio assay kit. To 1 ml of 
assay medium, 100 fil of plasma was added and the change in NADH concentration 
was detected by monitoring the decrease in absorbance at 340 nm for 120 seconds. 
Enzyme activity was calculated according to instructions of assay kit menu from the 
following equation: 
ALT activity (U/L) = [(AAat 340nm / Min) / 0.0063] x [1.10/0.10] 
= ( A A at 340nm / Min) x 1746 
5.2.3 Statistical analysis 
All analyses were performed in triplicate. The data were recorded as mean 
土 S.E. One-way analysis of variance was performed by ANOVA procedures using the 
SPSS version 12.0.1 for Windows (SPSS Inc., US). Significant differences between 
means compared were determined when P-values <0.05. 
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5.3 Results 
5.3.1 Dose-dependent effect of WZ-e on menadione hepatotoxicity 
The plasma ALT activity in control group was estimated to be 12.24 土 1.06 
U/L. Menadione treatment caused a significant increase in plasma ALT activity (59.1 
±25.9) when compared with the control. The plasma ALT activity of WZ-e treated mice 
at low (0.42 g/kg/day), medium (1.25 g/kg/day) and high (3.75 g/kg/day) doses were 
found to be 50.08 士 9.16 U/L, 31.88 士 10.32 U/L, and 57.99 ± 20.63 U/L, 
respectively, following menadione treatment (Figure 5.1). As a dose of 1.25g/kg/day 
offered the best hepatoprotection, this dosage was chosen to carry out the subsequent 
Orthogonal analysis experiments even though the protective effect was not 
statistically significant. 
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Control Menadione Catechin- WZ-e (low)- WZ-e (med)- WZ-e (high)-menadione meandione menadione menadione Figure 5.1 Effects of WZ-e on menadione-induced hepatotoxicity in mice. 
Female ICR mice were treated intragastrically with WZ-e at different 
doses for 7 days. Menadione was injected into mice at 24 hours after the last dose. All mice were sacrificed 24 hours after menadione injection. Plasma ALT activity was measured sing a commercialassay kit Data are expr ssed as me n 土 S.D. (n = 5) 
+ P < 0.05 compared with control group. 
* P < 0.05 compared with menadione-treated control group. 
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5.3.2 Dose-dependent effect of WZ-e on menadione hepatotoxicity as 
illustrated by histopathological observations 
Histological changes associated with the treatment with WZ-e at low dose 
(0.42 g/kg/day), medium dose (1.25 g/kg/day) and high dose (3.75 g/kg/day) were 
examined in menadione-treated mice. As shown in Figure 5.2 and 5.3, the liver of 
menadione-intoxicated mice showed gross necrosis and loss of cellular boundary of 
cells around the terminal hepatic venule (central vein) (LefKowitch, 1989; Ruebner, 
1991). Histological pattern of livers from WZ-e pretreated mice with 
menadione-induced toxicity also showed some degree of necrosis and loss of cellular 
boundary around central vein. The areas of affected regions in low and medium 
dosage groups were smaller and a lower degree of inflammation was observed when 
compared to the high dosage group. 
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Figure 5.2 The histopathological conditions of the liver sections in menadione 
challenged mice pretreated with catechin and WZ-e (400x). (a) 
control; (b) menadione treatment; (c) catechin + menadione treatement; 
(d) WZ-e low dosage + menadione treatment; (e) WZ-e medium 
dosage + menadione treatment; (f) WZ-e + menadione treatment. 
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Figure 5.3 The histopathological conditions of the liver sections in menadione 
challenged mice pretreated with catechin and WZ-e (630x). (a) 
control; (b) menadione treatment; (c) catechin + menadione treatement; 
(d) WZ-e low dosage + menadione treatment; (e) WZ-e medium 
dosage + menadione treatment; (f) WZ-e + menadione treatment. 
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5.3.3 Analyzing the effect of WZ-e and its simplified formulae on 
menadione-induced hepatotoxicity by Orthogonal Analysis 
Through Orthogonal analysis, formulae (2)-8, (2)-3, WZ-e, (2)-l，（2)-7， 
(3)-10, FS and (2)-5 were suggested by the computer program to be the experimental 
groups. The results of these groups are shown in Figure 5.2. For formulae (2)-5, 
the plasma ALT value is 11.44 土 2.86 U/L，which is the lowest among all groups. 
Formula (2)-5 thus had a significant hepato-protective effect on menadione toxicity. 
On the other hand, it is interesting to note that formula (2)-8 displayed a high plasma 
ALT activity, indicating a hepatotoxic effect. However, Orthogonal analysis showed 
no significant difference among all 5 ingredients of WZ. 
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Figure 5.4 Hepatoprotective effect of WZ-e and selected simplified formulae 
on menadione-treated mice. Female ICR mice were treated 
intragastrically with WZ-e and selected simplified formulae for 7 days. 
Menadione was injected at 24 hours after the last dose. All mice were 
sacrificed 24 hours after menadione injection. Plasma ALT activity 
was measured using commercial assay kit. Results are expressed as 
mean 士 S.D. (n = 5). 
+ P < 0.05 compared with control group. 
* P < 0.05 compared with menadione-treated control group. 
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5.4 Discussion 
The results indicated that the protective effect of WZ-e was better at 
medium dose (1.25 g/kg/day) than at low dose (0.42 g/kg/day). However, at the 
highest dosage (3.75 g/kg/day), the extract was found to produce hepatotoxic effect, 
with resultant increase in plasma ALT. 
The WZ-e was found to protent against menadione-induced toxicity (Table 
5.1 and Table 5.2). This result observation is consistant with the in vitro results 
obtained in Trolox equivalent antioxidant capacity (TEAC) assay. However, 
Orthogonal analysis indicated no significant difference in the effect of the 5 main 
ingredients in the WZ formula. In other words, none of the 5 ingredients plays a 
leading role in the WZ prescription. Therefore, this finding is contradictory to the 
result of TEAC assay, in which FR is the most significantly important component in 
the formula. 
The TEAC assay indicated that formulae (2)-8 and (2)-5 displayed strong 
antioxidant potential. In the in vivo test, however, (2)-8 was found to exhibit toxic 
effect in mice. In contrast, (2)-5 has an excellent protective effect on the menadione 
toxicity in mice. In this regard, SC and FR are the components in (2)-5. 
It has been reported that WZ formula could produce a protective effect on 
oxidative damage of mDNA in aged men and aged rats (Wang, 2001). No chronic 
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toxicity was observed for Wu-zi-yan-zong pill being taken orally for 8 weeks in SD 
rats (Xu, 2001). However, the effect of WZ on the oxidative damage in mice 
produced by menadione has not been reported in literature. In the present study, we 
have demonstrated the protective effect of WZ-e on menadione induced 
hepatotoxicity, as evidenced by both biochemical and histological parameters. 
It is worth nothing that aqueous extracts were used in all experiments, 
whereas the WZ formula, as recorded in Pharmacopoeia (2000), as used in pill form 
containing dried powders of raw plant materials. Since, aqueous extract was used in 
the present study, fat-soluble substances were not extracted from the herbal materials. 
As a result, the pharmacological effects of WZ-e used in the present study are 
deemed to be different from those of the traditional formulation. 
Taken together, the ensemble of results, it can be indicates that WZ-e 
possesses an in vivo antioxidant activity in protecting against menadione-induced 
hepatotoxicity and a combination of SC and FR could be optional in producing the 
hepato-protective effect. However, further investigation should be performed to 
examine the hepatoprotective potential of the combined SC and FR formula. 
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Conclusion 
Wu-zi-yan-zong-wan (WZ) is a tradition Chinese Medicinal formula which 
is indicated for kidney deficiency. In the present study, an aqueous extract of WZ was 
shown to possess antioxidant capacity in TEAC assay while Fructus Rubi (FR) was 
determined to be the strongest antioxidant component herb. This suggests that the 
simplification of WZ might optimize the antioxidant potential of WZ. On the other 
hand, both WZ-e and WZ-p enhanced cell viability in HepG2 cells in the presence of 
hydrogen peroxide. However, there is no evidence showing the relative importance 
of the ingredient herbs of WZ in terms of cytoprotection against H202-induced 
oxidation stress. In vivo study showed that WZ-e (1.25g/kg/day) produced 
hepato-protective effect against menadione-induced toxicity, as evidenced by a 
decrease in plasma ALT activity. However, through an Orthogonal Analysis, it was 
found that none of the ingredients in the WZ formula would have a critical role for 
the hepato-protecting action. 
In summary, it is concluded that the aqueous extract of WZ possesses 
antioxidant activity in both in vitro and in vivo assay system. Further investigations 
should be carried out to delineate the role of the ingredient herbs in producing 
antioxidant action and the biochemical mechanism involved in the cyto-and 
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hepato-protection. 
� 
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